Any Parkinson disease in which the cause of the disease is a mutation in the PINK1 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
The limited documentation surrounding autosomal recessive early-onset Parkinson disease 6 can be attributed to its rarity and the recent identification of its genetic basis. Conditions like this often affect fewer individuals, which results in fewer systematic clinical studies. Additionally, the overlap of symptoms with other forms of Parkinson's disease complicates the ability to characterize this condition fully.
To navigate your care effectively, consider seeking a neurologist with expertise in movement disorders, particularly those focused on hereditary Parkinson's disease. Genetic counseling is also recommended, as it can provide insights into the implications of PINK1 mutations for you and your family. While no patient organizations are currently identified, you can explore resources from the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also be a valuable option.
Currently, there is one active clinical trial related to autosomal recessive early-onset Parkinson disease 6. This trial may provide insights into potential therapies and management strategies. You can find more information about this trial at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=autosomal%20recessive%20early-onset%20Parkinson%20disease%206.
Actionable guidance for navigating care for autosomal recessive early-onset Parkinson disease 6
To navigate your care effectively, consider seeking a neurologist with expertise in movement disorders, particularly those focused on hereditary Parkinson's disease. Genetic counseling is also recommended, as it can provide insights into the implications of PINK1 mutations for you and your family. While no patient organizations are currently identified, you can explore resources from the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for additional support and information. Participating in clinical trials may also be a valuable option.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.